BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 46 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,616 | -58.3% | 10,125 | +9.7% | 0.00% | – |
Q2 2023 | $61,492 | -64.3% | 9,233 | +0.0% | 0.00% | -100.0% |
Q1 2023 | $172,232 | -11.4% | 9,230 | +2.0% | 0.00% | 0.0% |
Q4 2022 | $194,308 | +81.6% | 9,046 | -0.4% | 0.00% | 0.0% |
Q3 2022 | $107,000 | -9.3% | 9,079 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $118,000 | -34.1% | 8,951 | +4.6% | 0.00% | 0.0% |
Q1 2022 | $179,000 | -3.8% | 8,561 | -6.6% | 0.00% | 0.0% |
Q4 2021 | $186,000 | -35.0% | 9,163 | -2.9% | 0.00% | -50.0% |
Q3 2021 | $286,000 | +14.9% | 9,437 | +10.2% | 0.00% | +100.0% |
Q2 2021 | $249,000 | -22.4% | 8,564 | +15.0% | 0.00% | 0.0% |
Q1 2021 | $321,000 | -6.4% | 7,448 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $343,000 | +12.8% | 7,429 | +6.0% | 0.00% | 0.0% |
Q3 2020 | $304,000 | -11.4% | 7,010 | +8.3% | 0.00% | -50.0% |
Q2 2020 | $343,000 | +272.8% | 6,473 | +57.5% | 0.00% | +100.0% |
Q1 2020 | $92,000 | +46.0% | 4,109 | -5.5% | 0.00% | – |
Q4 2019 | $63,000 | +133.3% | 4,346 | +14.2% | 0.00% | – |
Q3 2019 | $27,000 | -35.7% | 3,807 | -0.7% | 0.00% | – |
Q2 2019 | $42,000 | – | 3,833 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |